---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-02-09T11:18:25.116452'
end_time: '2026-02-09T11:26:18.718068'
duration_seconds: 473.6
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: PFDN6
  gene_symbol: PFDN6
  uniprot_accession: O15212
  protein_description: 'RecName: Full=Prefoldin subunit 6; AltName: Full=Protein Ke2;'
  gene_info: Name=PFDN6; Synonyms=HKE2, PFD6;
  organism_full: Homo sapiens (Human).
  protein_family: Belongs to the prefoldin subunit beta family.
  protein_domains: PFD_beta-like. (IPR002777); Prefoldin. (IPR009053); Prefoldin_2
    (PF01920)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
citation_count: 19
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** O15212
- **Protein Description:** RecName: Full=Prefoldin subunit 6; AltName: Full=Protein Ke2;
- **Gene Information:** Name=PFDN6; Synonyms=HKE2, PFD6;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the prefoldin subunit beta family.
- **Key Domains:** PFD_beta-like. (IPR002777); Prefoldin. (IPR009053); Prefoldin_2 (PF01920)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "PFDN6" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'PFDN6' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **PFDN6** (gene ID: PFDN6, UniProt: O15212) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** O15212
- **Protein Description:** RecName: Full=Prefoldin subunit 6; AltName: Full=Protein Ke2;
- **Gene Information:** Name=PFDN6; Synonyms=HKE2, PFD6;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the prefoldin subunit beta family.
- **Key Domains:** PFD_beta-like. (IPR002777); Prefoldin. (IPR009053); Prefoldin_2 (PF01920)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "PFDN6" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'PFDN6' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **PFDN6** (gene ID: PFDN6, UniProt: O15212) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Plan status: Identity verification completed. Literature gathered and synthesized from recent structural, mechanistic, and disease-focused sources (2020–2024). A compact source table is embedded for quick reference to URLs and publication dates.

Key concepts and definitions (current understanding)
- Gene/protein identity and family: PFDN6 (UniProt O15212) encodes prefoldin subunit 6, a beta-class subunit of the canonical eukaryotic prefoldin complex (PFDN1–6). Prefoldin is a conserved heterohexamer (2 alpha + 4 beta subunits) with a jellyfish-like architecture of coiled-coil “tentacles” that capture non-native polypeptides via hydrophobic distal tips; PFDN6 is one of the four beta subunits in this assembly (clockwise subunit order models place PFDN6 between PFDN5 and PFDN4). Canonical function is to escort nascent cytoskeletal clients (actin/tubulin) to the group II chaperonin TRiC/CCT for ATP-driven folding (i.e., a co-chaperone “holdase” and substrate-delivery role) (herranzmontoya2021acomprehensiveanalysis pages 1-2, herranzmontoya2021acomprehensiveanalysis pages 2-4, herranzmontoya2021acomprehensiveanalysis pages 4-5, liang2020thefunctionsand pages 1-2, tahmaz2022prefoldinfunctionin pages 1-2).
- Relationship to TRiC/CCT: Prefoldin binds unstructured clients and interfaces with TRiC/CCT to transfer clients into the open TRiC chamber, facilitating productive engagement with the chaperonin for folding to native state. This division of labor—ATP-independent capture/transfer (prefoldin) and ATP-dependent folding (TRiC)—is a central paradigm in eukaryotic cytosolic proteostasis (gestaut2023structuralvisualizationof pages 1-3, liang2020thefunctionsand pages 1-2, herranzmontoya2021acomprehensiveanalysis pages 1-2).

Structural features and domains
- Subunit/complex architecture: Beta-class prefoldin subunits (including PFDN6) share the PFD_beta-like fold, contributing one coiled-coil “tentacle” bearing hydrophobic residues near the tip to engage exposed hydrophobic patches on non-native substrates. The assembled heterohexamer presents six tentacles surrounding a double beta-barrel hub; flexible tentacles underpin broad client capture and hand-off to TRiC/CCT (liang2020thefunctionsand pages 1-2, herranzmontoya2021acomprehensiveanalysis pages 1-2, herranzmontoya2021acomprehensiveanalysis pages 4-5).
- Client transfer mechanism (recent mechanistic detail): Cryo-EM visualization of human TRiC folding of tubulin captured progressive client states in the TRiC chamber, consistent with upstream prefoldin hand-off into an open ring followed by ATP-driven closure and domain-wise maturation of tubulin; electrostatic interactions and dynamic CCT tails stabilize intermediates on the path to native tubulin (Cell, Apr 2023) (gestaut2023structuralvisualizationof pages 1-3).

Cellular localization and nuclear functions
- Cytosol and nucleus: While the canonical role is cytosolic client capture/transfer, prefoldin subunits (including beta subunits) exhibit nucleo-cytoplasmic distribution and have non-canonical nuclear roles. Reported functions include transcriptional regulation and links to proteasome-dependent protein turnover, indicating that prefoldin contributes to protein homeostasis beyond cytoskeletal folding (review synthesis) (tahmaz2022prefoldinfunctionin pages 1-2). 

Experimentally supported clients and pathways
- Cytoskeletal clients and TRiC pathway: Actin and tubulin are obligate clients of TRiC/CCT; prefoldin captures these nascent chains and promotes their efficient delivery and folding. Recent structural work resolved multiple tubulin folding intermediates inside TRiC, consistent with prefoldin-to-TRiC hand-off and a hierarchical folding trajectory driven by TRiC’s ATPase cycle (gestaut2023structuralvisualizationof pages 1-3, liang2020thefunctionsand pages 1-2, herranzmontoya2021acomprehensiveanalysis pages 1-2).
- Broader proteostasis context: Reviews synthesize additional client/process connections for the prefoldin network, including protection from aggregation and participation in protein quality control, with individual subunits exhibiting specialized or independent functions within and beyond the hexamer (tahmaz2022prefoldinfunctionin pages 1-2, herranzmontoya2021acomprehensiveanalysis pages 1-2).

Recent developments (2023–2024; prioritized) and quantitative data
- Structural mechanism of prefoldin–TRiC cooperation (2023): High-resolution cryo-EM of human TRiC with tubulin visualizes sequential, domain-resolved folding within the closed chamber, grounded in prior prefoldin hand-off to open TRiC; the study details electrostatic anchoring, client translocation upon ring closure, and roles for CCT C-termini in stabilizing folding nuclei (Cell, Apr 2023; URL above) (gestaut2023structuralvisualizationof pages 1-3).
- Human cancer context for PFDN6 (2024): A colorectal cancer study integrated TCGA (635 tumors vs 51 normal) and immunohistochemistry on 106 CRC vs 96 para-cancer tissues, and performed PFDN6 knockdown in CRC cell lines with downstream transcriptome profiling and migration phenotyping—together supporting a functional contribution of PFDN6 to CRC biology via transcriptional impacts (eGastroenterology, Apr 2024; URL: https://doi.org/10.1136/egastro-2023-100001). Quantitatively, the study reports cohort sizes (TCGA and IHC) and deploys knockdown validation by qRT-PCR and immunoblot prior to phenotypic and transcriptomic assays (xu2024pfdn6contributesto pages 2-3).

Current applications and real-world implementations
- Proteostasis/structural biology: The prefoldin–TRiC paradigm is directly leveraged in structural proteomics workflows to capture endogenous chaperone–client complexes for cryo-EM, enabling visualization of on-pathway folding states in human cells (e.g., tubulin–TRiC structures), which informs targetable interfaces and chaperone-assisted maturation steps relevant to disease-associated proteostasis defects (gestaut2023structuralvisualizationof pages 1-3).
- Cancer biology and biomarker exploration: Integrative analyses and functional perturbations in CRC models place PFDN6 within tumor-associated transcriptional programs, offering a basis for biomarker and mechanistic exploration in oncology cohorts (cohort sizes and modality mix as above) (xu2024pfdn6contributesto pages 2-3).

Expert opinions and analysis from authoritative sources
- Cancer-focused synthesis: A comprehensive analysis positions PFDN6 within the canonical prefoldin complex and notes broader links to a mammalian unconventional prefoldin-like (URI-containing) assembly that connects to transcriptional regulators, suggesting that prefoldin subunits—including PFDN6—may influence nuclear gene expression programs in addition to cytosolic folding (iScience, Nov 2021; URL: https://doi.org/10.1016/j.isci.2021.103273) (herranzmontoya2021acomprehensiveanalysis pages 2-4, herranzmontoya2021acomprehensiveanalysis pages 8-10, herranzmontoya2021acomprehensiveanalysis pages 4-5).
- Proteostasis review: A 2022 review outlines prefoldin’s ATP-independent holdase and client-transfer roles to TRiC, its nucleo-cytoplasmic localization, and its participation in protein quality control and disease processes, highlighting that individual subunits can have functions independent of the holo-hexamer (Frontiers in Cell and Developmental Biology, Jan 2022; URL: https://doi.org/10.3389/fcell.2021.816214) (tahmaz2022prefoldinfunctionin pages 1-2).

Disease associations and PFDN6-specific links
- Colorectal cancer: In human CRC, PFDN6 was studied using large-scale datasets (TCGA), tissue immunohistochemistry, and perturbation assays in multiple CRC cell lines, with transcriptome profiling following PFDN6 knockdown—together supporting a role for PFDN6 in CRC-associated transcriptional regulation and cell behavior (eGastroenterology, Apr 2024; URL: https://doi.org/10.1136/egastro-2023-100001) (xu2024pfdn6contributesto pages 2-3).
- Additional disease contexts (reviewed): Prefoldin subunits—beta subunits included—have been implicated broadly in cancer and proteostasis disorders; reviews note individual subunit associations with disease phenotypes and stress responses (herranzmontoya2021acomprehensiveanalysis pages 1-2, tahmaz2022prefoldinfunctionin pages 1-2). While these reviews summarize connections, direct human PFDN6-specific mechanistic disease studies remain comparatively limited and are emerging.

Mechanistic pathway placement for PFDN6
- Primary role: PFDN6 functions as one beta subunit in the canonical prefoldin hexamer that captures non-native clients (e.g., nascent actin/tubulin) and delivers them to TRiC/CCT. This places PFDN6 squarely in the cytosolic chaperone network upstream of TRiC, modulating proteostasis and cytoskeletal biogenesis (liang2020thefunctionsand pages 1-2, gestaut2023structuralvisualizationof pages 1-3, herranzmontoya2021acomprehensiveanalysis pages 1-2).
- Non-canonical nuclear contributions (inferred from complex-level evidence): Prefoldin subunits can localize to the nucleus and influence gene expression and protein quality control pathways, suggesting that PFDN6, as part of the holo-complex, may contribute to transcription-related processes described for prefoldin in human cells (review evidence) (tahmaz2022prefoldinfunctionin pages 1-2, herranzmontoya2021acomprehensiveanalysis pages 1-2).

Relevant statistics and data from recent studies
- Cryo-EM structural series (Cell 2023): Multiple near-atomic structures of human TRiC with tubulin across its ATPase cycle resolved client positions, contacts, and folding progression, delineating a stepwise pathway from open-state client engagement (consistent with prefoldin hand-off) to closed-state near-native tubulin (publication date Apr 2023; URL above) (gestaut2023structuralvisualizationof pages 1-3).
- CRC cohorts and assays (eGastroenterology 2024): TCGA cohort size 635 tumors vs 51 normal; IHC on 106 CRC vs 96 para-cancer tissues; functional PFDN6 knockdown in RKO and HCT-116 followed by transcriptome profiling and migration assays, establishing experimental links between PFDN6 perturbation and CRC cell phenotypes (publication date Apr 2024; URL above) (xu2024pfdn6contributesto pages 2-3).

Verification of ambiguity and alignment with UniProt context
- The gene symbol “PFDN6” unambiguously corresponds to human prefoldin subunit 6 (beta family) within the canonical prefoldin heterohexamer, consistent with the provided UniProt accession O15212 and domain/family annotations (PFD_beta-like, Prefoldin). Literature cited above consistently treats PFDN6 as a human prefoldin beta subunit; no conflicting organismal/gene symbol usage was found in the gathered evidence (herranzmontoya2021acomprehensiveanalysis pages 1-2, liang2020thefunctionsand pages 1-2).

Embedded source table
| Year | Reference (journal) | Focus/relevance to PFDN6 | URL |
|---|---|---|---|
| 2024 | Xu F. et al., eGastroenterology | PFDN6 upregulation in colorectal cancer; IHC/TCGA analysis and knockdown phenotypes linking PFDN6 to transcriptional regulation of CRC (xu2024pfdn6contributesto pages 2-3) | https://doi.org/10.1136/egastro-2023-100001 |
| 2023 | Gestaut D. et al., Cell | Cryo-EM visualization of TRiC-mediated tubulin folding showing prefoldin hand-off and mechanistic details of prefoldin→TRiC substrate delivery (gestaut2023structuralvisualizationof pages 1-3) | https://doi.org/10.1016/j.cell.2023.04.004 |
| 2021 | Payán-Bravo L. et al., Nucleic Acids Research | Human prefoldin binds chromatin and modulates RNA Pol II Ser2 phosphorylation and co-transcriptional splicing (related nuclear functions summarized here) (herranzmontoya2021acomprehensiveanalysis pages 2-4) | https://doi.org/10.1101/2020.06.14.150466 |
| 2018 | Banks C.A.S. et al., Scientific Reports | Prefoldin/CCT involvement in HDAC1/2 complex assembly and evidence for nuclear processing roles of prefoldin pathway (herranzmontoya2021acomprehensiveanalysis pages 2-4) | https://doi.org/10.1038/s41598-018-32009-w |
| 2021 | Herranz-Montoya I. et al., iScience | Canonical prefoldin architecture; PFDN6 as a beta-class subunit; links to UPC/URI prefoldin-like assemblies and cancer relevance (herranzmontoya2021acomprehensiveanalysis pages 2-4, herranzmontoya2021acomprehensiveanalysis pages 8-10) | https://doi.org/10.1016/j.isci.2021.103273 |
| 2022 | Tahmaz I. et al., Frontiers in Cell Dev. Biol. | Review of prefoldin function in proteostasis and human disease; discusses individual subunit roles and reported disease links for PFDN6 (tahmaz2022prefoldinfunctionin pages 1-2) | https://doi.org/10.3389/fcell.2021.816214 |
| 2020 | Liang J. et al., Cell & Bioscience | Structural description of prefoldin ("jellyfish" heterohexamer), beta-subunit features and substrate-binding tentacles relevant to PFDN6 function (liang2020thefunctionsand pages 1-2) | https://doi.org/10.1186/s13578-020-00446-8 |


*Table: Compact summary table of authoritative references (2020–2024) about human PFDN6/prefoldin, indicating each paper's focus on PFDN6 function, structure, nuclear roles, prefoldin–TRiC cooperation, or disease relevance, with DOI URLs and context citations for traceability.*

Conclusions and outstanding questions
- PFDN6 is a core beta subunit of the canonical prefoldin co-chaperone that captures non-native substrates and delivers them to TRiC/CCT for folding; this role is supported by structural and mechanistic advances that visualize client maturation inside human TRiC (2023). The complex-level evidence indicates nucleo-cytoplasmic distribution and contributions to transcriptional regulation and proteostasis beyond cytoskeletal folding. Recent oncology data (2024) place PFDN6 within CRC-associated transcriptional programs with supporting multi-cohort and perturbation evidence, though additional PFDN6-specific mechanistic dissection in human disease is warranted to define causal roles and therapeutic leverage points (gestaut2023structuralvisualizationof pages 1-3, tahmaz2022prefoldinfunctionin pages 1-2, xu2024pfdn6contributesto pages 2-3, herranzmontoya2021acomprehensiveanalysis pages 1-2, liang2020thefunctionsand pages 1-2).

References (URLs and publication dates embedded above via citations)

References

1. (herranzmontoya2021acomprehensiveanalysis pages 1-2): Irene Herranz-Montoya, Solip Park, and Nabil Djouder. A comprehensive analysis of prefoldins and their implication in cancer. iScience, 24:103273, Nov 2021. URL: https://doi.org/10.1016/j.isci.2021.103273, doi:10.1016/j.isci.2021.103273. This article has 24 citations and is from a peer-reviewed journal.

2. (herranzmontoya2021acomprehensiveanalysis pages 2-4): Irene Herranz-Montoya, Solip Park, and Nabil Djouder. A comprehensive analysis of prefoldins and their implication in cancer. iScience, 24:103273, Nov 2021. URL: https://doi.org/10.1016/j.isci.2021.103273, doi:10.1016/j.isci.2021.103273. This article has 24 citations and is from a peer-reviewed journal.

3. (herranzmontoya2021acomprehensiveanalysis pages 4-5): Irene Herranz-Montoya, Solip Park, and Nabil Djouder. A comprehensive analysis of prefoldins and their implication in cancer. iScience, 24:103273, Nov 2021. URL: https://doi.org/10.1016/j.isci.2021.103273, doi:10.1016/j.isci.2021.103273. This article has 24 citations and is from a peer-reviewed journal.

4. (liang2020thefunctionsand pages 1-2): Jiaxin Liang, Longzheng Xia, Linda Oyang, Jinguan Lin, Shiming Tan, Pin Yi, Yaqian Han, Xia Luo, Hui Wang, Lu Tang, Qing Pan, Yutong Tian, Shan Rao, Min Su, Yingrui Shi, Deliang Cao, Yujuan Zhou, and Qianjin Liao. The functions and mechanisms of prefoldin complex and prefoldin-subunits. Cell & Bioscience, Jul 2020. URL: https://doi.org/10.1186/s13578-020-00446-8, doi:10.1186/s13578-020-00446-8. This article has 70 citations and is from a peer-reviewed journal.

5. (tahmaz2022prefoldinfunctionin pages 1-2): Ismail Tahmaz, Somayeh Shahmoradi Ghahe, and Ulrike Topf. Prefoldin function in cellular protein homeostasis and human diseases. Frontiers in Cell and Developmental Biology, Jan 2022. URL: https://doi.org/10.3389/fcell.2021.816214, doi:10.3389/fcell.2021.816214. This article has 48 citations and is from a poor quality or predatory journal.

6. (gestaut2023structuralvisualizationof pages 1-3): Daniel Gestaut, Yanyan Zhao, Junsun Park, Boxue Ma, Alexander Leitner, Miranda Collier, Grigore Pintilie, Soung-Hun Roh, Wah Chiu, and Judith Frydman. Structural visualization of the tubulin folding pathway directed by human chaperonin tric/cct. Cell, 186:2038, Apr 2023. URL: https://doi.org/10.1016/j.cell.2023.04.004, doi:10.1016/j.cell.2023.04.004. This article has 73 citations and is from a highest quality peer-reviewed journal.

7. (xu2024pfdn6contributesto pages 2-3): Fenghua Xu, Lingyang Kong, Xiao Sun, Wen-Xiang Hui, Lan Jiang, Wenxin Han, Zhifeng Xiao, Ning Li, Dong-feng Chen, Nan Zheng, Jing Han, and Lei Liu. Pfdn6 contributes to colorectal cancer progression via transcriptional regulation. eGastroenterology, 2:e100001, Apr 2024. URL: https://doi.org/10.1136/egastro-2023-100001, doi:10.1136/egastro-2023-100001. This article has 0 citations and is from a peer-reviewed journal.

8. (herranzmontoya2021acomprehensiveanalysis pages 8-10): Irene Herranz-Montoya, Solip Park, and Nabil Djouder. A comprehensive analysis of prefoldins and their implication in cancer. iScience, 24:103273, Nov 2021. URL: https://doi.org/10.1016/j.isci.2021.103273, doi:10.1016/j.isci.2021.103273. This article has 24 citations and is from a peer-reviewed journal.

## Citations

1. gestaut2023structuralvisualizationof pages 1-3
2. tahmaz2022prefoldinfunctionin pages 1-2
3. herranzmontoya2021acomprehensiveanalysis pages 2-4
4. liang2020thefunctionsand pages 1-2
5. herranzmontoya2021acomprehensiveanalysis pages 1-2
6. herranzmontoya2021acomprehensiveanalysis pages 4-5
7. herranzmontoya2021acomprehensiveanalysis pages 8-10
8. https://doi.org/10.1136/egastro-2023-100001
9. https://doi.org/10.1016/j.isci.2021.103273
10. https://doi.org/10.3389/fcell.2021.816214
11. https://doi.org/10.1016/j.cell.2023.04.004
12. https://doi.org/10.1101/2020.06.14.150466
13. https://doi.org/10.1038/s41598-018-32009-w
14. https://doi.org/10.1186/s13578-020-00446-8
15. https://doi.org/10.1016/j.isci.2021.103273,
16. https://doi.org/10.1186/s13578-020-00446-8,
17. https://doi.org/10.3389/fcell.2021.816214,
18. https://doi.org/10.1016/j.cell.2023.04.004,
19. https://doi.org/10.1136/egastro-2023-100001,